Discovering the true signals of disease to power life-changing drugs.
90% of drug candidates fail, delaying help for those in need. We’re on a mission to change that. Better drug target discovery powered by the Newfoundland founder effect.
What they do:
Arpeggio Bio develops drugs targeting transcription factors using AI…
Quick facts:
HQ: Boulder, CO, United States
What they do:
Discovering drugs that target the DNA regulome
Quick facts:
HQ: Seattle, WA, United States
What they do:
Using CRISPR to find treatments for cancer and inflammation
Quick facts:
HQ: San Francisco, CA, United States
What they do:
We create activating antibodies to treat diseases others can’t.
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Adventris makes cancer vaccines
Quick facts:
HQ: Baltimore, MD, United States
What they do:
Artificial intelligence for drug discovery.
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$19.8M · Equity · Mar 2026
Discovering the true signals of disease to power life-changing drugs.
St. John's, Canada
52 employees, according to the company profile.
There are no funding rounds for Sequence Bio in our data.
Similar startups: Arpeggio Bio, Talus Bio, and Algen Biotechnologies.